Selank

A seven-amino-acid tuftsin analogue developed in Moscow as an anxiolytic; human data are a few small, open Russian trials with no placebo arm.

Also known as: TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro, Tuftsin analogue
Area: Cognitive
Status: Used clinically in Russia; not approved as a medicine in the UK, EU or US

Articles on Selank

CognitiveHuman study

Selank: what the anxiety trials actually tested, and where

Selank’s human evidence is a handful of small Russian studies without placebo groups, most from the team that made it. Promising on paper, unproven by any independent standard.

HPR Editorial · 1 Aug 2026 · 7 min read